SLC7A5 and lung carcinoma: showed that SLC7A5 is expressed in non-small cell lung cancer (NSCLC) and that 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH) inhibits SLC7A5 to reduce the viability of lung cancer cells.14